Cargando…

Toxicity to intravitreal melphalan in a patient with retinoblastoma

Objective: Description of melphalan’s toxicity in retinoblastoma treatment. Methods: Clinical case report. Results: We presented a case of unilateral retinoblastoma with vitreous seeding at diagnosis, in which the use of intravitreal melphalan produced many adverse reactions. Conclusions: Vitreous s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solaz-Ruiz, Marta Gema, Pérez, Lorena Azorín, Cauto-Picazo, Carlos, Barranco-González, Honorio, Pascual-Camps, Isabel, España-Gregori, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Romanian Society of Ophthalmology 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591425/ https://www.ncbi.nlm.nih.gov/pubmed/37876503 http://dx.doi.org/10.22336/rjo.2023.49

Ejemplares similares

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients
por: Xue, Kang, et al.
Publicado: (2019)

Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma
por: Hsieh, Terry, et al.
Publicado: (2020)

Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
por: Shah, Nisha V., et al.
Publicado: (2014)

Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2020)

Intravitreal melphalan for persistent retinoblastoma vitreous seeds
por: Redondo-Villanueva, Marie Jeazelle H., et al.
Publicado: (2022)

Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2021)

Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding
por: Alahmadi, Ghaida, et al.
Publicado: (2023)

Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
por: Ji, Xunda, et al.
Publicado: (2016)

Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report
por: Chao, An- Ning, et al.
Publicado: (2016)

Histopathologic findings after selective ophthalmic arterial injection of melphalan for retinoblastoma
por: Chen, Ho-Min, et al.
Publicado: (2019)

The role of intravitreal chemotherapy for retinoblastoma
por: Manjandavida, Fairooz P, et al.
Publicado: (2015)

Anesthetic management of super-selective intra-arterial Melphalan injection in an infant with retinoblastoma
por: Vaithialingam, Balaji, et al.
Publicado: (2023)

Combination intravitreous melphalan and bevacizumb for cutaneous metastatic melanoma to the vitreous and retina
por: Francis, Jasmine H., et al.
Publicado: (2022)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
por: Udaondo Mirete, Patricia, et al.
Publicado: (2023)

Multiple Differential Networks Strategy Reveals Carboplatin and Melphalan-Induced Dynamic Module Changes in Retinoblastoma
por: Chen, Cui, et al.
Publicado: (2016)

Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution
por: Thampi, Sheila, et al.
Publicado: (2013)

Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study
por: Bogan, Carley M, et al.
Publicado: (2022)

Atypical intravitreal growth of retinoblastoma with a multi-branching configuration
por: Nishina, Sachiko, et al.
Publicado: (2017)

Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy
por: Francis, Jasmine H., et al.
Publicado: (2018)

Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalan.
por: Alberts, D. S., et al.
Publicado: (1981)

Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report
por: Stathopoulos, Christina, et al.
Publicado: (2020)

The Safety and Effectiveness of Melphalan-Based Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Single-Arm Systematic Review and Meta-Analysis
por: Cao, Yang, et al.
Publicado: (2022)

Death by Water: Precautionary Water Submersion for Intravitreal Injection of Retinoblastoma Eyes
por: Francis, Jasmine H, et al.
Publicado: (2014)

Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity
por: Lin, Zhimei, et al.
Publicado: (2022)

Complete preclinical platform for intravitreal chemotherapy drug discovery for retinoblastoma: Assessment of pharmacokinetics, toxicity and efficacy using a rabbit model
por: Daniels, Anthony B., et al.
Publicado: (2021)

Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model
por: Kaczmarek, Jessica V., et al.
Publicado: (2021)

Retinoblastoma and mosaic 13q deletion: a case report
por: Gargallo, Pablo, et al.
Publicado: (2021)

Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma
por: Yu, Xiling, et al.
Publicado: (2020)

Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma
por: Dalvin, Lauren A
Publicado: (2022)

Ocular loiasis affecting a child and its assessment by Anterior Segment Optical Coherence Tomography
por: Placinta, Ioan Alexandru, et al.
Publicado: (2019)

Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan.
por: Moscow, J. A., et al.
Publicado: (1993)

Retinoblastoma in a 23-year-old adult treated with primary intra-arterial and intravitreal chemotherapy
por: McMahon, Jeffrey F., et al.
Publicado: (2019)

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
por: Lee, Se Ryeon, et al.
Publicado: (2019)

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
por: Pascual-Camps, Isabel, et al.
Publicado: (2014)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol
por: Amin, Saima, et al.
Publicado: (2020)

Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
por: Ge, Qunfang, et al.
Publicado: (2022)

Retracted: Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model
por: Delrish, Elham, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8bm1cfqf727c1s5gbmrrtinsi